Belite Bio (BLTE) Invested Capital (2020 - 2026)

Belite Bio's Invested Capital history runs 7 years deep, the most recent figure standing at $795.8 million for Q1 2026.

• In Q1 2026, Invested Capital rose 403.44% year-over-year to $795.8 million; the TTM figure through Mar 2026 stood at $795.8 million (up 403.44% YoY), while the FY2025 annual figure was $770.5 million, up 428.38% from the prior year.
• Invested Capital was $795.8 million for Q1 2026 at Belite Bio, up from $770.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $795.8 million in Q1 2026 to a low of $35.2 million in Q1 2023.
• Historically, Invested Capital has averaged $206.6 million across 5 years, with a median of $113.4 million in 2024.
• Biggest YoY gain for Invested Capital was 428.38% in 2025; the steepest drop was 30.8% in 2025.
• A 5-year view of Invested Capital shows it stood at $41.5 million in 2022, then surged by 117.9% to $90.4 million in 2023, then soared by 61.25% to $145.8 million in 2024, then soared by 428.38% to $770.5 million in 2025, then grew by 3.28% to $795.8 million in 2026.
• The last three Invested Capital figures came in at $795.8 million (Q1 2026), $770.5 million (Q4 2025), and $274.1 million (Q3 2025), per Business Quant data.